HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Suzanne F Jones Selected Research
Suzanne F Jones Research Topics
Disease
42
Neoplasms (Cancer)
11/2022 - 01/2002
9
Thrombocytopenia (Thrombopenia)
12/2015 - 05/2003
8
Nausea
03/2016 - 11/2005
8
Neutropenia
12/2015 - 05/2003
8
Diarrhea
08/2013 - 05/2003
7
Breast Neoplasms (Breast Cancer)
11/2021 - 01/2002
6
Fatigue
03/2016 - 06/2008
6
Exanthema (Rash)
08/2013 - 08/2005
5
Vomiting
03/2016 - 11/2005
5
Disease Progression
01/2014 - 05/2003
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 05/2003
4
Febrile Neutropenia
06/2013 - 11/2009
2
Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2016
2
Anorexia
03/2016 - 04/2009
2
Mucositis
02/2015 - 01/2010
2
Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 04/2013
2
Anemia
01/2014 - 06/2010
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2010 - 11/2009
2
Lung Neoplasms (Lung Cancer)
05/2005 - 05/2003
1
Microsatellite Instability
11/2021
1
Carcinogenesis
05/2020
1
Leiomyosarcoma
03/2016
1
Pain (Aches)
12/2015
1
Thrombocytopenia 1
02/2015
1
Hemorrhage
02/2015
1
Body Weight (Weight, Body)
01/2015
1
Edema (Dropsy)
01/2014
1
Uveitis
06/2013
1
Proteinuria
11/2011
Drug/Important Bio-Agent (IBA)
7
Pharmaceutical Preparations
IBA
05/2020 - 08/2005
7
Carboplatin (JM8)
FDA Link
Generic
12/2019 - 05/2003
5
Irinotecan (Camptosar)
FDA Link
Generic
01/2015 - 05/2003
4
Paclitaxel (Taxol)
FDA Link
Generic
09/2012 - 01/2002
4
Lapatinib (GW572016)
FDA Link
11/2009 - 08/2005
3
Pemetrexed (MTA)
FDA Link
12/2019 - 01/2010
3
pazopanib
FDA Link
08/2013 - 01/2010
3
Transaminases (Aminotransferases)
IBA
06/2013 - 01/2010
3
Gemcitabine
FDA Link
07/2012 - 01/2011
3
Trastuzumab (Herceptin)
FDA Link
04/2009 - 08/2005
2
Biomarkers (Surrogate Marker)
IBA
11/2022 - 11/2021
2
Immune Checkpoint Inhibitors
IBA
11/2022 - 11/2021
2
Proteins (Proteins, Gene)
FDA Link
12/2015 - 06/2011
2
Enzymes
IBA
12/2015 - 08/2013
2
romidepsin (FK228)
FDA Link
12/2015 - 07/2012
2
Capecitabine (Xeloda)
FDA Link
01/2015 - 05/2010
2
Tyrosine Kinase Inhibitors
IBA
08/2013 - 04/2009
2
Panobinostat
IBA
09/2012 - 03/2011
2
Topotecan (Hycamtin)
FDA Link
Generic
06/2010 - 01/2010
2
ErbB Receptors (EGF Receptor)
IBA
04/2009 - 08/2005
2
Docetaxel (Taxotere)
FDA Link
06/2008 - 05/2005
2
Gefitinib (Iressa)
FDA Link
09/2005 - 05/2003
1
cyclopropapyrroloindole
IBA
11/2022
1
adavosertib
IBA
01/2022
1
Platinum
IBA
01/2022
1
HSP27 Heat-Shock Proteins
IBA
12/2019
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
12/2019
1
apatorsen
IBA
12/2019
1
Antisense Oligonucleotides
IBA
12/2019
1
Messenger RNA (mRNA)
IBA
12/2019
1
LY900009
IBA
03/2016
1
Lipids
IBA
12/2015
1
Cytochrome P-450 CYP3A Inhibitors
IBA
12/2015
1
Rifampin (Rifampicin)
FDA Link
Generic
12/2015
1
Ketoconazole (Nizoral)
FDA Link
Generic
12/2015
1
Cytochrome P-450 CYP3A
IBA
12/2015
1
Ranitidine (Zantac)
FDA Link
Generic
12/2015
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
10/2015
1
defactinib
IBA
10/2015
1
dactolisib
IBA
04/2015
1
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
04/2015
1
ME-344
IBA
04/2015
1
Everolimus
FDA Link
02/2015
1
3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanol
IBA
02/2015
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
02/2015
1
5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamide
IBA
01/2015
1
Biological Products
IBA
07/2014
1
ME-143
IBA
02/2014
1
NADH oxidase
IBA
02/2014
1
human ALK1-Fc fusion protein
IBA
01/2014
1
Diuretics
IBA
01/2014
1
Ligands
IBA
01/2014
1
Activin Receptors (Activin Receptor)
IBA
01/2014
1
carfilzomib
IBA
10/2013
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2013
1
Proteasome Inhibitors
IBA
10/2013
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
08/2013
1
Epidermal Growth Factor (EGF)
IBA
08/2013
1
Monoclonal Antibodies
IBA
04/2013
1
Glycoproteins (Glycoprotein)
IBA
04/2013
1
KRN-330
IBA
04/2013
1
Angiogenesis Inhibitors
IBA
08/2012
1
vatalanib (PTK787)
IBA
11/2011
1
Bevacizumab (Avastin)
FDA Link
11/2011
Therapy/Procedure
10
Therapeutics
03/2016 - 05/2003
4
Drug Therapy (Chemotherapy)
01/2022 - 01/2011
1
Precision Medicine
11/2022
1
Time-to-Treatment
11/2021
1
Premedication
01/2016
1
Drug Tapering
08/2013
1
Oral Administration
09/2012